Pathogenesis of Mycobacterium tuberculosis Flashcards

1
Q

LOs

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Probability that TB is transmitted depends on:

A
  • Infectiousness of person with TB disease (dose)
  • environment in which exposure occured
  • length of exposure
  • virulence (strength) of tubercle bacilli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Best way to stop transmission of TB is:

A

isolate infectious persons

provide effective treatment to infectious persons ASAP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors for TB

A
  • Socioeconomic status
  • Crowding
  • Immune suppression
  • Health care workers
  • POVERTY
  • Overall health/ immune system status
  • Alcoholism
  • Smoking
  • Diabetes
  • TB within the last 2 years
  • HIV co-infection
  • Strain virulence?
  • Genetic predisposition?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

outcomes of exposure to TB

A

you get infected or you dont get infected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

out of those that do get infected, what 2 things can happen next?

A

you get dormant TB (90%) or you get active TB (10)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dormant TB

A

asymtpomatic, subclinical

no tB disease

not infectious to others

can last a lifetime

presence if cellular immune response

5-10 % risk of reactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

active TB

A

ill with symptoms and likely to die if left untreated

infectious

usually within 1-2 years of infection

result of local bacterial growth and dissemination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

activation of infection results in

A

disease

post primary infectino/ secondary TB

due to loss of immune control of infection (in the granuloma)

active disease presentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

infection sites of TB

A
  • Pulmonary containment- 85% (usually apices due to aerobic loving bacteria)
  • infection starts in lungs then spreads to many parts of the body
  • extrapulmonaryTB is generally non-contagious and occurs more frequently in immunosuppressed individuals

possible::

  • lymph nodes
  • liver
  • millliary- disseminated (sapced out in small lesions)
  • bones and joints as potts disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

methods of diagnosing TB

A
  • often based on symptomatic presentation alone- Persistent cough, fever, night sweats, wight loss, chest pain, fatigue, loss of appetite
  • mycobacterial culture- SLOW, Colonies are dry, raised, irregular, white and may become yellow
  • AFB smear- sputum microscopy, low sensitivity
  • radiography- CXR look for lymphadenopathy and calcification
  • Molecular approaches- genexpert TB
  • TST (tuberculin skin test)
  • Interferon gamma release test (IGRA) blood test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TST (tuberculin skin tests/ mantoux)

A

TB antigens are planted under the skin- monitor for a cell mediated immune response

Creates indurations (bump less than 5mm no infection), oedema at site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Problems with TST

A
  • Cross reactivity with the BCG vaccination
  • Cannot distinguish active from latent very well
  • Low sensitivity (identify those with disease) and specificity (generate negative result for those who don’t have it)
  • Reader variability (some will say you have it vs some wont)
  • No good in HIV as. No immune response
  • Requires multiple visits, reading after 48-72 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

interferon gamma release assay

A
  • blood test used to test for TB
  • measures IFN-gamma production in whole blood response to stimulation with MTb antrigens
  • these antigens are not present in BCG strains and do not cross react with the environmental antigens

positives- quick

negatives- does not distinguish between active and latent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

prevention, treatment and resistance

A
  • priority in case origin identification and treatment
  • primarily of active TB in resource limiting settings
  • infection in kids can be common
  • HIV is hard to treat with TB
  • few new drugs
  • long chemotherapeutic treatments (months)- toxicity and resistance issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what vaccine do we give for TB?

A
  1. BCG- M.bovis attenuated strain
  2. stops the DEVELOPMENT of infection. does not stop its progression
  3. protective against severe infection in children
  4. some efficacy in severity of disease among those vaccinated
  5. efficacy varies rgeatly depending on the levels of TB in the population
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

antitubercle drugs

A

combination therapy (this prevents resistance to one drug)

isoniazid with pyridoxine

rifampicin and ethambutol

long treatment period- come back and review for bacterial ab sensitivity

complex disease mau require monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what are the 4 main drugs used to treat TB

A

isoniazid + pyridoxine

rifampicin + ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

fluoroquinolone

A

inhibs DNA synthesis and supercoiling by targeting topoisomerases

23
Q

rifamycin

A

: inhibs RNA synthesis by targeting RNA polymerase

24
Q

streptomycin

A

inhibs protein synthesis by trgeting 30S subunit

25
26
macrolides
target 23S ribosomal RNA, inhinbiting peptidyl transferase
27
isoniazid and theionamide
inhibs mycolic acid synthesis
28
ethambutol and pyrasinamide
inhibs cell wall synthesis
29
relevance of mycolic acid in TB
found in the cell wall helps the organism survive inside macrophages
30
inherent defences of TB against drugs
drugs cannot penetrate cell wall low pH- renders drug inactive efflux pumps- drug removed from cell before it reaches the target anaerobic conditions lead to dormant/ non-replicating state- drugs that block metabolic processes have no effect during state of dormancy
31
TB emergence of resistance
slow replicative rate- more time for mutations to accrew mutations to TSG and proto-oncogenes lead to multiple drug resistance alterations in enzymes means that pro-drugs arent converted to their active forms alteration of drug target composition means that the drug cant be recognised
32
Mycobacterium resistance types
MDR-TB X-DR
33
multidrug resistant TB
develeoping during treatment process to 2 (isoniazid and rifampcin) this is natural. treat with second line drugs
34
XDR- TB
extended. includes resistance to secind and third line drugs. there is no standardized treatment available
35
mycobacterium tuberculosis complex
group of organisms that will casue infections in humans Mycobacterium tuberculosis Bovis (BCG) Africanum and many more These can all casue TB iun humans and animals (zoonotic) all members have different host preferences all are obligate pathogens show 990.5% sequence similarity within the group
36
general characteristics of mycobacterium
slightly curved rod shaped bacilli aerobic non motile can show filamentous branching (myco) thick lipid rich cell wall can remain dormant, non-spore forming multiplies slowly **_acid-fast_** resists stain decolouristaion with acid/ alcohol
37
cell wall of mtb
* peptidoglycan wall aboce lipid bilayer * behaves like gram positive * lipid rich structure- mycolic acids * unique and responsible for much of its virukence * plasma membrane associated proteins * Cord factor-inhibits migration of leukocytes, causes chronic granulomas
38
mycolic acid
characteristic of mycobacterium acid fastness immunostimulatory
39
mtb pathogenesis
* Majority of pathology has been related to the host immune response to infection * Pathogen also plays a role in its own virulence * Some strains are more pathogenic than others * Known virulence factors are used to subvert the host immunity (efflux pumps)
40
early progression of TB
First 4-6 weeks Exposure →innate response (chance for elimination) →adaptive response (Chance for elim) Organism hides from immune system in granulomas →years to decades →granuloma degrades and releases bacteria 
41
stages of infection
disease course has 3 main stages: 1. **_Invasion-_** pre-cellular immune response 2. **_Persistance-_** post cellular response 3. **_Reactivation-_** secondary acute infection-
42
stage 1 invasion
* Mtb is a facultative intracellular pathogen requires replication in macrophages * mtb initiates macrophage phagocytosis by making contact with macrophage mannose, complement and TOLL- like 2 receptors * Reside in phagosome * Receptors utilised are those associated with an innate response like C-type lectin receptors (CLRs), nod-like receptors (NLRs), scavenger rectpors, complement receptors and toll-like receptors (TLR) * Some prevent lysis in phagolysosome by preventing fusion * The ability to infect macrophages is a key pathogenic determinant for bacterial spread
43
why can this organism use so many receptors to invade cells
* cell wall complexity allows it to interact with multiple receptors * mtb surviving may ne dependant on the receptors incolved during phagocytosis (some receptors normally lead to phagocytosis) * a) e.g., via the CR3 receptor which inhibits macrophage activation
44
problem with using receptors in innate immunity
tb can use them to invade cells
45
induction of cellular immunity
* TH1 mediated immunity is crucial * you want more th1 involvement than th2 * production of IFN- gamma by T cells leads to macrophage activation and death of Mtb infected cells cellular immunity is crucial for controllimng TB. HIV targets and kills these cells making reactivation more likely to occur
46
macrophage reactivation by the cellular immune system
* interferon gamma overcomes the endosome like arrest that mtb imposes, delivering the vacteria to autolysosomes where growth is stopped. * * mtb fights thhis by resisting oxidatice stress and suverting cell death pathways (necrosis and apoptosis) * if necrotic, pieces will disseminate into other areas
47
stage 2 inhibition of phagosomal maturation
**_Mtb causes:_** * Impaired fusion of phagosome with lysosome * Inhibition of phagosome acidification * Inefficient recruitment of proton ATP-ase pump * Results in lack of acidification of the phagosome * Modified maturation of phagosome * Overexpression of Rab5 on the phagosomes harbouring bacilli causes maturation arrest at early endosomal stage
48
graniuloma in MTB infection
Organised aggregate of immune cells that surround a foci of infected tissues. classic lesion seen in MTB infection infected macrophages produce a strong pro inflam response TNF-a is key. these signal recuit more cells to the site
49
steps in tubercle/ granuloma formation
macrophages alone arent enough for intiation of the granuloma forming multinucleated giant cells (MGCs) infected macrophages release tnf-a to attract more cells mtb products participate in granuloma production- something mtb wants as part of pathogenesis foamy macrophages T cells and B cells and neutrophils
50
kinds of granuloma (5)
ficrocalcific non-necrotic caseous suppurative cavitary
51
factors associated with bacterial latency
ability to alter phagolysosome maturation mtb can persist within endosomes for years centre of the granuloma is hypoxic, little nutrient availabilty, low pH → causes a shift in response (latency associated genes) → dormancy allows organism to survive
52
Stage 3 MTB reactivation
likely due to the host immune response caused by immune suppresion of some sort HIV is a potent factor for reactivation for latency Rescusitation promoting factors are critical components for revival tissue destruction allows for bacterial dissemination and transmission